|Mr. Joshua R. Disbrow||Chairman & CEO||465k||N/A||1975|
|Mr. David A. Green||CFO, Sec. & Treasurer||345k||N/A||1963|
|Mr. Jarrett T. Disbrow Ph.D.||Exec. VP of Corp. Devel.||355k||N/A||1975|
|Mr. Matthew V. Phillips||Exec. VP of Commercial Operations||N/A||N/A||1968|
Aytu BioScience, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. The company markets Natesto, a nasal gel for the treatment of hypogonadism (low testosterone) in men; and Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension. It also offers ZolpiMist, an oral spray for the treatment of insomnia; and MiOXSYS, an in vitro diagnostic semen analysis test that is used in the measurement of static oxidation reduction potential in human semen. Aytu BioScience, Inc. is based in Englewood, Colorado.
Aytu BioScience, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.